BiotechTube

YHP1701 + YHR1703 + YHR1704

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypertension and Hyperlipidemia

Conditions

Hypertension and Hyperlipidemia

Trial Timeline

May 17, 2017 → Apr 30, 2018

NCT ID
NCT03103256

About YHP1701 + YHR1703 + YHR1704

YHP1701 + YHR1703 + YHR1704 is a phase 3 stage product being developed by Yuhan for Hypertension and Hyperlipidemia. The current trial status is completed. This product is registered under clinical trial identifier NCT03103256. Target conditions include Hypertension and Hyperlipidemia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03103256Phase 3Completed

Competing Products

20 competing products in Hypertension and Hyperlipidemia

See all competitors
ProductCompanyStageHype Score
macitentan 10 mgBML, Inc.Phase 3
76
tadalafil + tadalafilEli LillyPhase 3
77
CS1 AdministrationCereno ScientificPhase 2
47
CS1Cereno ScientificPre-clinical
18
TX000045- Dose A + TX000045- Dose B + PlaceboTectonic TherapeuticPhase 2
44
Dose A KER-012 + Dose B KER-012 + Dose C KER-012 + Placebo for 24 Weeks followed by Dose B KER-012 for 72 weeksKeros TherapeuticsPhase 2
44
Tirzepatide + Tirzepatide PlaceboEli LillyApproved
85
L04RD1 + L04TD3CelltrionPhase 1
33
Azilsartan MedoxomilCelltrionPre-clinical
23
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mgCelltrionPhase 3
77
Satralizumab (Genetical Recombination)Chugai PharmaceuticalPhase 2
52
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
85
Telmisartan + Amlodipine + ChlorthalidoneYuhanPhase 1
33
Temisartan/Amlodipine+Rosuvastatin + YHP1604YuhanPhase 1
33
Temisartan+Amlodipine+Rosuvastatin (Combination drug) + Temisartan+Amlodipine + Temisartan+RosuvastatinYuhanPhase 3
77
Amlodipine + ValsartanYuhanApproved
85
Duowell® + TelmisartanYuhanApproved
85
YH22189 + Twynsta 80/10mg + Crestor 20mgYuhanPhase 1
33
OM 40 + OM/HCTZ 40/12.5Daiichi SankyoPhase 3
77
Rosuvastatin+Valsartan (Sequence 1) + Rosuvastatin+Valsartan (Sequence 2) + Rosuvastatin+Valsartan (Sequence 3) + Rosuvastatin+Valsartan (Sequence 4) + Rosuvastatin+Valsartan (Sequence 5) + Rosuvastatin+Valsartan (Sequence 6)YuhanPhase 1
33

Other Products from Yuhan

generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)Approved
85
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidApproved
85
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgApproved
85
Atorvastatin 20mg loading + Atorvastatin 80mg loadingApproved
85